Page 188 - Read Online
P. 188

Koseki et al.                                                                                                                                                             Inflammatory cells in intracranial aneurysm

               Dysregulation of CD4(+) T Cell Subsets in Intracranial Aneurysm. DNA   of the novel proinflammatory supergene “intercrine” cytokine family.
               Cell Biol 2016;35:96-103.                         Annu Rev Immunol 1991;9:617-48.
           22.  Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview.   41.  Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2-
               Methods Mol Biol 2006;315:13-34.                  expressing myeloid-derived suppressor cells are essential to promote
           23.  Stassen M, Hultner L, Muller C, Schmitt E. Mast cells and inflammation.   colitis-associated tumorigenesis. Cancer Cell 2013;24:631-44.
               Arch Immunol Ther Exp (Warsz) 2002;50:179-85.  42.  Ma X, Aoki T, Tsuruyama T, Narumiya S. Definition of Prostaglandin
           24.  Bacci  S,  Pieri  L,  Buccoliero AM,  Bonelli A,  Taddei  G,  Romagnoli   E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify
               P. Smooth muscle cells, dendritic cells and mast cells are sources of   Inflammation and Tumor Growth. Cancer Res 2015;75:2822-32.
               TNFalpha  and  nitric  oxide  in  human  carotid  artery  atherosclerosis.   43.  Murray  PJ,  Wynn  TA.  Protective  and  pathogenic  functions  of
               Thromb Res 2008;122:657-67.                       macrophage subsets. Nat Rev Immunol 2011;11:723-37.
           25.  Bhattacharyya  SP,  Drucker  I,  Reshef  T,  Kirshenbaum AS,  Metcalfe   44.  Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S,
               DD, Mekori YA. Activated T lymphocytes induce degranulation and   Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani
               cytokine production by human mast cells following cell-to-cell contact.   A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL,
               J Leukoc Biol 1998;63:337-41.                     Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN,
           26.  Dumitrascu D. Mast cells as potent inflammatory cells. Rom J Intern   Wynn TA. Macrophage activation and polarization: nomenclature and
               Med 1996;34:159-72.                               experimental guidelines. Immunity 2014;41:14-20.
           27.  Kagami S, Kanari H, Suto A, Fujiwara M, Ikeda K, Hirose K, Watanabe   45.  Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen
               N, Iwamoto I, Nakajima H. HMG-CoA reductase inhibitor simvastatin   N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T. Critical
               inhibits proinflammatory cytokine production from murine mast cells.   roles of macrophages in the formation of intracranial aneurysm. Stroke
               Int Arch Allergy Immunol 2008;146 Suppl 1:61-6.   2011;42:173-8.
           28.  Nakae S, Iikura M, Suto H, Akiba H, Umetsu DT, Dekruyff RH, Saito   46.  Shojima M, Oshima M, Takagi K, Torii R, Hayakawa M, Katada K,
               H, Galli SJ. TIM-1 and TIM-3 enhancement of Th2 cytokine production   Morita A, Kirino T. Magnitude and role of wall shear stress on cerebral
               by mast cells. Blood 2007;110:2565-8.             aneurysm:  computational  fluid  dynamic  study  of  20  middle  cerebral
           29.  Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T,   artery aneurysms. Stroke 2004;35:2500-5.
               Kruger-Krasagakes S. Comparative cytokine gene expression: regulation   47.  Alfano  JM,  Kolega  J,  Natarajan  SK,  Xiang  J,  Paluch  RA,  Levy  EI,
               and release by human mast cells. Immunology 1998;93:289-95.  Siddiqui AH, Meng H. Intracranial aneurysms occur more frequently at
           30.  Ali AS, Lax AS, Liljestrom M, Paakkari I, Ashammakhi N, Kovanen PT,   bifurcation sites that typically experience higher hemodynamic stresses.
               Konttinen YT. Mast cells in atherosclerosis as a source of the cytokine   Neurosurgery 2013;73:497-505.
               RANKL. Clin Chem Lab Med 2006;44:672-4.        48.  Dolan JM, Kolega J, Meng H. High wall shear stress and spatial gradients
           31.  Chaldakov GN, Valchanov K, Tonchev A, Ghenev PI. The association   in vascular pathology: a review. Ann Biomed Eng 2013;41:1411-27.
               of  mast  cells  and  atherosclerosis:  new  insights  into  mast  cells  in   49.  Aoki T, Narumiya S. Prostaglandins and chronic inflammation. Trends
               atherogenesis. Hum Pathol 1995;26:1286.           Pharmacol Sci 2012;33:304-11.
           32.  Sun  J,  Sukhova  GK,  Wolters  PJ,  Yang  M,  Kitamoto  S,  Libby  P,   50.  Neuwelt A, Sidhu N, Hu CA, Mlady G, Eberhardt SC, Sillerud LO.
               MacFarlane  LA,  Mallen-St  Clair  J,  Shi  GP.  Mast  cells  promote   Iron-based superparamagnetic nanoparticle contrast agents for MRI of
               atherosclerosis  by  releasing  proinflammatory  cytokines.  Nat Med   infection and inflammation. AJR Am J Roentgenol 2015;204:W302-13.
               2007;13:719-24.                                51.  Zhao X, Zhao H, Chen Z, Lan M. Ultrasmall superparamagnetic iron
           33.  Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P, Sun   oxide nanoparticles for magnetic resonance imaging contrast agent. J
               C, Zhang Y, Liu J, Ennis TL, Knispel R, Xiong W, Thompson RW, Baxter   Nanosci Nanotechnol 2014;14:210-20.
               BT, Shi GP. Mast cells modulate the pathogenesis of elastase-induced   52.  Hasan DM, Mahaney KB, Magnotta VA, Kung DK, Lawton MT, Hashimoto
               abdominal aortic aneurysms in mice. J Clin Invest 2007;117:3359-68.  T, Winn HR, Saloner D, Martin A, Gahramanov S, Dosa E, Neuwelt E,
           34.  Aoki T, Nishimura M. The development and the use of experimental   Young WL. Macrophage imaging within human cerebral aneurysms wall
               animal models to study the underlying mechanisms of CA formation. J   using ferumoxytol-enhanced MRI: a pilot study. Arterioscler Thromb Vasc
               Biomed Biotechnol 2011;2011:535921.               Biol 2012;32:1032-8.
           35.  Ishibashi  R,  Aoki  T,  Nishimura  M,  Hashimoto  N,  Miyamoto  S.   53.  Hasan DM, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta
               Contribution of mast cells to cerebral aneurysm formation.  Curr   VA, Young WL, Hashimoto T, Richard Winn H, Heistad D. Evidence
               Neurovasc Res 2010;7:113-24.                      that  acetylsalicylic  acid  attenuates  inflammation  in  the  walls  of
           36.  Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N.   human cerebral aneurysms: preliminary results.  J Am  Heart Assoc
               Impact of monocyte chemoattractant protein-1 deficiency on cerebral   2013;2:e000019.
               aneurysm formation. Stroke 2009;40:942-51.     54.  Hasan D, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta
           37.  Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Macrophage-  VA, Young WL, Hashimoto T, Winn HR, Heistad D. Early change
               derived matrix metalloproteinase-2 and -9 promote the progression of   in ferumoxytol-enhanced  magnetic  resonance imaging signal
               cerebral aneurysms in rats. Stroke 2007;38:162-9.  suggests unstable human cerebral  aneurysm: a pilot  study.  Stroke
           38.  Moriwaki  T,  Takagi Y,  Sadamasa  N, Aoki  T,  Nozaki  K,  Hashimoto   2012;43:3258-65.
               N. Impaired progression of cerebral aneurysms in interleukin-1beta-  55.  Chalouhi N, Jabbour P, Magnotta V, Hasan D. Molecular imaging of
               deficient mice. Stroke 2006;37:900-5.             cerebrovascular lesions. Transl Stroke Res 2014;5:260-8.
           39.  Kataoka H, Aoki T. Molecular basis for the development of intracranial   56.  Querol  M,  Chen  JW,  Bogdanov  AA  Jr.  A  paramagnetic  contrast
               aneurysm. Expert Rev Neurother 2010;10:173-87.    agent  with  myeloperoxidase-sensing  properties.  Org Biomol Chem
           40.  Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties   2006;4:1887-95.







                           Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ August 31, 2016             179
   183   184   185   186   187   188   189   190   191   192   193